Dermatology News

Smartphone applications that use algorithms to assess the risk for skin cancer appear to have poor and variable performance, according to a systematic review of diagnostic accuracy studies.

MAUI, HAWAII — Clinicians should avoid prescribing opioids when treating venous leg ulcers, a speaker at Maui Derm said.

MIAMI BEACH, Fla. — While the armamentarium of acne treatment is vast, various novel treatments are on the horizon, according to a presenter at South Beach Symposium.

Dermatopathology reports may need to be redesigned to increase patient comprehension due to the lack of understanding patients have of current reports, according to a research letter published in JAMA Dermatology.

Eli Lilly and Company and Incyte announced that baricitinib met its primary endpoint in the BREEZE-AD4 and BREEZE-AD5 studies in patients with moderate to severe atopic dermatitis, according to two press releases.

MAUI, HAWAII — In a discussion hosted by the Women’s Dermatologic Society, panelists aligned with private equity-backed groups focused on whether independent dermatology practices can survive given the impact of private equity, burnout and diminishing revenue.

MAUI, HAWAII — Dermatologists who visit the website for Dupixent may be inclined to believe the monoclonal antibody only treats atopic dermatitis, asthma and chronic rhinosinusitis. Similarly, a glance at Stelara’s website may prompt readers to think it only treats Crohn’s disease and ulcerative colitis.

MAUI, HAWAII — There are several ways that dermatologists in the United States can help infectious disease specialists keep the number of measles and coronavirus cases to a minimum, according to a speaker here at Maui Derm for Dermatologists 2020.

MAUI, HAWAII — Though approximately 25% of patients with psoriasis will eventually develop psoriatic arthritis, it remains unclear which patients will, according to a presentation here at Maui Derm for Dermatologists 2020.

MAUI, HAWAII — Several different psoriasis treatments, including those that would provide much needed relief for pediatric patients, are currently making their way through the product pipeline, two panelists at Maui Derm for Dermatologists 2020 said.